DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Low Cylinder Toric

Information source: Alcon Research
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Cataracts

Intervention: Toric IOL (SN60T3) (Device)

Phase: Phase 4

Status: Completed

Sponsored by: Alcon Research


Study evaluates the visual outcomes and patient satisfaction after implantation of a toric intraocular lens (IOL).

Clinical Details

Official title: Evaluation of the Acrysof Toric Model SN60T3 Intraocular Lens in Patients With Predicted Residual Corneal Astigmatism Between 0.75 and 1.03 Diopters (D)

Study design: Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Primary outcome:

Uncorrected Distance Visual Acuity

Best Corrected Distance Visual Acuity

Residual Refractive Cylinder

Secondary outcome: Patient Satisfaction Survey


Minimum age: 21 Years. Maximum age: N/A. Gender(s): Both.


Inclusion Criteria:

- Diagnosed with Cataracts

- Predicted residual corneal astigmatism between 0. 75 and 1. 03 Diopters (D)

Exclusion Criteria:

- Preoperative ocular pathology

- Planned monovision

Locations and Contacts

Alcon Call Center for Trial Locations, Fort Worth, Texas 76134, United States
Additional Information

Starting date: June 2007
Last updated: March 25, 2010

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017